CCL20 and lung cancer: Wang et al. [34] found that IL-1β can stimulate lung cancer cells to produce CCL20 by activating the MAPK and PI3K signaling pathways, and the autocrine of CCL20 can promote the migration and proliferation of lung cancer cells by initiating the ERK and PI3K signaling pathways.